Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kevin Thiongo"'
Autor:
Gabriel M. Kishoyian, Damaris Matoke-Muhia, Francis Kimani, George O. Orinda, Eliud N.M. Njagi, Kevin Thiongo
Publikováno v:
Epidemiology and Infection
Background The resistance of Plasmodium falciparum to antimalarial drugs remains a major impairment in the treatment and eradication of malaria globally. Following the introduction of artemisinin-based combination therapy (ACT), there have been repor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d05ce7560a908f7887b1e91c3ccf2f0
https://pubmed.ncbi.nlm.nih.gov/33397548
https://pubmed.ncbi.nlm.nih.gov/33397548
Autor:
gabriel m kishoyian, Eliud N.M. Njagi, George O. Orinda, Francis T. Kimani, Kevin Thiongo, Damaris Matoke-Muhia
Background: Plasmodium falciparum resistance to antimalarial drugs remains to be a major threat to the control of the disease globally. After the deployment of artemisinin-based combination therapy (ACT), there have been reports of reduced sensitivit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f8009d61d900acbdbd4cd2e9cfe6b3d6
https://doi.org/10.21203/rs.3.rs-22339/v2
https://doi.org/10.21203/rs.3.rs-22339/v2
Autor:
Gabriel M. Kishoyian, Eliud N. M. Njagi, George O. Orinda, Francis T. Kimani, Kevin Thiongo, Damaris Matoke-Muhia
Background: Plasmodium falciparum resistance to antimalarial drugs remains to be a major threat to the control of malaria globally. After the deployment of artemisinin-based combination therapy (ACT), there have been reports of reduced sensitivity of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::db49caa719f5adc34c2cd7e802a0a235
https://doi.org/10.21203/rs.3.rs-22339/v1
https://doi.org/10.21203/rs.3.rs-22339/v1
Autor:
George O. Orinda, Damaris Matoke Muhia, Gabriel M. Kishoyian, Francis Kimani, Eliud N.M. Njagi, Kevin Thiongo
Background: The application of chloroquine (CQ) as an antimalarial drug for over half a century and subsequent development of CQ-resistant Plasmodium strains has led to its withdrawal and replacement with sulphadoxine-pyrimethamine (SP). In 2004, SP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3221ea53b173cb1d1885ad685bbcab13
https://doi.org/10.21203/rs.2.9218/v1
https://doi.org/10.21203/rs.2.9218/v1
Autor:
Kishoyian, Gabriel, Njagi, Eliud N. M., Orinda, George O., Kimani, Francis T., Thiongo, Kevin, Matoke-Muhia, Damaris
Publikováno v:
Epidemiology & Infection; Oct2021, Vol. 149, p1-9, 9p